Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine vs Labetalol for Postoperative Hemodynamic Control in Hemorrhagic Stroke
NCT07364201Completed
- Sponsor
- Universitas Sumatera Utara
- Start
- Nov 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypertension (HTN) comparing Nicardipine with Labetalol (2 arms). Primary endpoint: Effectiveness of Hemodynamic Control at 24 hours. Started Nov 2025; status: completed.
02
Drugs
nicardipinelabetalol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07364201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07364201.